1673-422X
2012 Issue 12
Hypermethylated in cancer 1 and neoplasms
GUO Shu-qin;MA Jing-jing;ZHANG Yun-liang
GUO Shu-qin;MA Jing-jing;ZHANG Yun-liang
..............page:883-886
GRIM-19 gene and tumor
SHAO Yu-pei;WAN Xiao-yun
SHAO Yu-pei;WAN Xiao-yun
..............page:886-888
Hypoxia inducible factor-1α and tumor
WANG Rui;LIAO Sheng-tao;LIU Yun-lai
WANG Rui;LIAO Sheng-tao;LIU Yun-lai
..............page:889-892
Runx2 and tumor metastasis
GENG Wen-wen;ZHANG Bin;CAO Xu-chen
GENG Wen-wen;ZHANG Bin;CAO Xu-chen
..............page:892-894
..............page:912,915,920
Histone deacetylase 7 and tumor angiogenesis
XU Xing-dong;YANG Bo
XU Xing-dong;YANG Bo
..............page:895-898
Mechanisms of immune suppression mediated by myeloid derived suppressor cells and the targeted therapy strategy
WEN Lan-lan;GAO Quan-li;MAI Ling
WEN Lan-lan;GAO Quan-li;MAI Ling
..............page:898-902
Radiation in head and neck cancers and the parotids' changes
WEI Shuang;HAO Jun-fang
WEI Shuang;HAO Jun-fang
..............page:913-915
Strategy of anti-angiogenesis and antiangiogenic drugs in NSCLC
ZHAO Xiang-fei;NIE Qing;KANG Jing-bo
ZHAO Xiang-fei;NIE Qing;KANG Jing-bo
..............page:916-920
Cancer stem cells and multidrug resistance
XU Gui-fang;ZHANG Wei-jie;ZHOU Zhi-hua;ZOU Xiao-ping
XU Gui-fang;ZHANG Wei-jie;ZHOU Zhi-hua;ZOU Xiao-ping
..............page:902-904
miRNA in breast cancer
L(U) Ping;YU Jiang-liu;YANG Hong-jian;LING Zhi-qiang
L(U) Ping;YU Jiang-liu;YANG Hong-jian;LING Zhi-qiang
..............page:921-924
Anti-tumor effect of type Ⅲ interferon
WANG Qing;ZHANG Lu;SHEN Qian-ni;ZHU Ni;LUO Fan;HOU Wei
WANG Qing;ZHANG Lu;SHEN Qian-ni;ZHU Ni;LUO Fan;HOU Wei
..............page:905-907
Progression of lobaplatin for cancer
SUN Na;YANG Wen-yan
SUN Na;YANG Wen-yan
..............page:907-909
Roles of bisphosphonate in the adjuvant treatment of breast cancer
LI Xu-yuan;LIN Ying-cheng
LI Xu-yuan;LIN Ying-cheng
..............page:925-928
Anticancer effect of crocin
XIA Dan
XIA Dan
..............page:910-912
Postoperative adjuvant radiotherapy for breast ductal carcinoma in situ
LIU Zhi-yan;LIU Wei-shuai;WANG Ping
LIU Zhi-yan;LIU Wei-shuai;WANG Ping
..............page:928-931
Study progress of malignant tracheoesophageal fistula
XU Guang;YU Hui-ming;HAN Da-li;YU Jin-ming
XU Guang;YU Hui-ming;HAN Da-li;YU Jin-ming
..............page:932-935
Significance of microsatellite instability in colorectal cancer
ZHI Wen-xue;SHI Su-sheng
ZHI Wen-xue;SHI Su-sheng
..............page:935-938
Advances in study of cervical small cell carcinoma
ZHANG Ying-li;CHEN Ya-qing;ZHENG Ai-wen
ZHANG Ying-li;CHEN Ya-qing;ZHENG Ai-wen
..............page:939-941
Research progress in T-cell lymphoblastic lymphoma
LIU Xiao-lan;SU Li-ping
LIU Xiao-lan;SU Li-ping
..............page:942-944
MMP-9 gene polymorphism and cancer risk: a meta-analysis
SU Tong;SHI Li;WEI Gai-jie;CHEN Jing
SU Tong;SHI Li;WEI Gai-jie;CHEN Jing
..............page:945-949
..............page:950-952
..............page:953-954